Prevention of Ebola Infection
1 clinical trials · Condition
◉ Watch Prevention of Ebola Infection
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) (NCT02503202) | Merck Sharp & Dohme LLC | 2015-08-17 |
Track Prevention of Ebola Infection automatically
Every clearance here is in the API, with alerts when new ones post.